WEBINAR: PURENERGY Provides Formulators Ability to Reduce Caffeine in Products by 50% Without Sacrifice to Consumers' Expectations

Over the past year, highly caffeinated energy beverages and products have been coming under increased regulatory and consumer scrutiny due to the possible risks of consuming high amounts of caffeine. Therefore, consumer and governmental groups have advocated for increased regulation of caffeinated products. Developed as a high-quality caffeine alternative by ChromaDex® Inc., PURENERGY™ provides the energy market with a solution to address growing regulatory scrutiny and consumer expectations.

PURENERGY is a novel patent-protected ingredient that offers a healthy, functional caffeine solution, and more importantly, it offers the same energy-related benefits as traditional caffeine while enabling a reduction in the amount of caffeine needed in a formulation to produce those results expected by consumers.

The first human clinical study of PURENERGY was completed by Miami Research Association (MRA), and the results confirmed that PURENERGY offers statistically significant energy-related benefits over traditional caffeine.

Join Douglas Kalman, Ph.D., RD, FACN, Director, Endocrinology & Nutrition Division Applied Clinical Trials with MRA as he covers:

  • Results from the first human clinical study
  • PURENERGY's applications of use
  • How PURENERGY can be a solution given the current regulatory landscape.

Register to view the archived event.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.